Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00625365 · ClinicalTrials.gov registry record · Phase 4
A Prospective, Phase IV, Surveillance Registry Study to Evaluate the Safety of DEFINITY® in Clinical Practice
A Phase 4 study, sponsored by Lantheus Medical Imaging.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,060
- Enrollment target
NCT00625365: Completed Phase 4 study, sponsored by Lantheus Medical Imaging.
NCT00625365 is a Phase 4 study that has completed, run by Lantheus Medical Imaging. The registered enrollment target is 1,060 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (105% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00625365, a Phase 4 study, has completed, sponsored by Lantheus Medical Imaging.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,060 participants
- Enrollment target
Study Summary
The purpose of this registry study is to gather safety information on the current clinical use of and the safety of DEFINITY®
Interventions
- DRUG DEFINITY®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,060 participants |
| Start Date | 2008-02 |
| Est. Completion | 2009-07 |
| Phase | Phase 4 |
What the finished NCT00625365 record still lists
NCT00625365 is an interventional study that assigns participants to a tested intervention. Its 1,060 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (105% higher).
The record links to 0 conditions, and to 1 intervention - of which DEFINITY® is the first listed.
NCT00625365 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00625365 about?
NCT00625365 is a clinical study titled "A Prospective, Phase IV, Surveillance Registry Study to Evaluate the Safety of DEFINITY® in Clinical Practice". The purpose of this registry study is to gather safety information on the current clinical use of and the safety of DEFINITY®
What is the current status of trial NCT00625365?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,060 participants. The study started on 2008-02. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00625365?
The interventions under investigation include: DEFINITY® (DRUG).
Who is sponsoring clinical trial NCT00625365?
This trial is sponsored by Lantheus Medical Imaging, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00625365's enrollment target sits among peer trials
1,060 66th of 2000 higher than 1,935 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05520762 · 1,060 participants · NA
Hospital Airway Resuscitation Trial
- NCT05911568 · 1,060 participants
Treatment With Endovascular Intervention for STroke Patients With Existing Disability
- NCT07140172 · 1,060 participants · NA
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
- NCT05125302 · 1,059 participants · Phase 3
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia